Eli Lilly warns the public about impurities in compounded preparations of tirsepatide. Tirzepatide mixed with vitamin B12 creates an impurity in humans with unknown effects. The company hereby draws attention to the potential risks of such mixtures. No other statistics or details about the study are provided in the content provided.